Where is the clean ammonia market headed?

Where is the clean ammonia market headed?

Up next

Commercial uses (and misuses) of AI in the chemicals sector

Jay Bhatia, founder and CEO of Agilis, an AI-enabled software provider for chemicals, joins the podcast to discuss the development of outward-facing AI tools in the industry. Key topics include the importance of master data management, why context is critical for building accurat ...  Show more

Dow's Fitterling and ACC's Jahn on the state of the industry

In two live interviews from the 2026 World Petrochemical Conference, Dow CEO Jim Fitterling and American Chemistry Council CEO Chris Jahn discuss the state of the industry in a moment of heightened volatility. Fitterling discusses the potential impact of the Middle East war, give ...  Show more

Recommended Episodes

Net Zero Transitions: Blue carbon
Argus Media

Adam Nye, VP of Business Development for Argus Global Carbon Markets, talks to Nadeem Khan, CEO and Founder of Indus Delta Capital, and Chris Villiers, Director of Portfolio Management at Respira, about blue carbon, including:  

<ul><li>Key fundamentals and co-benefits of ...  Show more

Martin Werner of DD3 Capital on the Codere / DDMX SPAC deal
Yet Another Value Podcast

Martin Werner, co-founding partner of DD3 Capital, discusses DDMX's deal to deSPAC with Codere Online. Key topics include what DDMX was looking for in a deal, how DDMX worked with their partners in structuring their deal, and why DDMX thinks Codere Online's omnichannel ...  Show more

Feeling Good about Feeling Good
The Dividend Cafe

Today's Post - https://bahnsen.co/4fktJ0n

Exploring Market Optimism Amid Economic Trends and Forecasts

In this edition of Dividend Cafe, host David Bahnsen discusses the current optimism in small and large businesses as ca ...

  Show more

Checking In On The Housing Market… And The Future of Pharma & Health Care 2/18/25
CNBC's "Fast Money"

A check in on the housing market, as builder sentiment drops to a 5-month low. The concerns they have over looming tariffs, and the latest results out of one of the top players in the space. Plus Pharma in focus, as the country’s health agencies deal with funding cuts and pers ...

  Show more